TipRanks
Advertisement

CH:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
16Bullish
6Neutral
0Bearish
Oscillators
Buy
4Bullish
6Neutral
0Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.54, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 23.02, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 21.79, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Oct 13, 2026, 11:01 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
23.70
23.70
23.70
23.70
23.70
23.70
23.70
Fibonacci
23.70
23.70
23.70
23.70
23.70
23.70
23.70

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Oct 13, 2026, 11:01 PM
Period
Simple
Exponential
MA5
23.47Buy
23.45Buy
MA10
23.49Buy
23.37Buy
MA20
23.07Buy
23.02Buy
MA50
21.73Buy
21.79Buy
MA100
19.66Buy
20.34Buy
MA200
18.13Buy
19.04Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 23.37, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 20.34, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 21.73, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 19.66, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 18.13, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Oct 13, 2026, 11:01 PM
Name
Value
Action
RSI (14)
58.09
Neutral
STOCH (9,6)
36.89
Neutral
STOCHRSI (14)
38.21
Neutral
MACD (12,26)
0.54
Buy
ADX (14)
32.22
Neutral
Williams %R
-46.88
Buy
CCI (14)
59.95
Neutral
ATR (14)
0.46
-
Ultimate Oscillator
53.70
Neutral
ROC
4.17
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 58.09, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 32.22, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 59.95, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 4.17, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Strong Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 58.09, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.54, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 23.47, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 23.07, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 21.73, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 18.13, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -46.88, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 59.95, which suggests CURE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement